Original Source(s)
Related Content
Residual risk in cardiovascular and renal diseases and the potential role of aldosterone synthase inhibitors
May 29, 2026
Recognizing the Transition to Advanced Heart Failure Earlier
Despite major advances in guideline-directed medical therapy (GDMT), worsening heart failure continues to drive significant morbidity, repeat hospitalizations and healthcare utilization worldwide.